Spironolactone in the treatment of polycystic ovary syndrome: effects on clinical features, insulin sensitivity and lipid profile. (Q46426588)
Jump to navigation
Jump to search
scientific article published in January 2005
Language | Label | Description | Also known as |
---|---|---|---|
English | Spironolactone in the treatment of polycystic ovary syndrome: effects on clinical features, insulin sensitivity and lipid profile. |
scientific article published in January 2005 |
Statements
Spironolactone in the treatment of polycystic ovary syndrome: effects on clinical features, insulin sensitivity and lipid profile (English)
E Zulian
P Sartorato
S Benedini
G Baro
D Armanini
1 January 2005
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference